New Delhi/Bengaluru [India], July 20 (ANI): Pharmaceutical company Mylan on Monday announced the commercial launch of its Remdesivir under the brand name DESREM™ in India to address urgent, unmet needs amid COVID-19 pandemic.
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.